Background illustration for clinical trials search

Paid Clinical Trials Richardson

Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: Dallas TX, McKinney TX, El Paso TX, Nashville TN,
Sponsor: Population Health Research Institute

Sex: All

Age: 18+

Code: NCT04774159

Phase 3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

for
Atrial Fibrillation (AF)
Location: Dallas TX, McKinney TX, Lufkin TX, Houston TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07430956

Phase 3, Recruiting

Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes

for
Dehydration
Location: Plano TX, Chicago IL, Bradenton FL, Valhalla NY
Sponsor: PepsiCo Global R&D

Sex: All

Age: 14 - 65

Code: NCT06212518

Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Dallas TX, Houston TX, Denver CO, Chicago IL,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase 3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Dallas TX, Austin TX, Houston TX, Birmingham AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Austin TX, Nashville TN, Atlanta GA,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase 1, Phase 2, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: Dallas TX, Austin TX, Odessa TX, Columbia MO,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase 3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Dallas TX, Fort Worth TX, Tyler TX, Oklahoma City OK,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Dallas TX, Topeka KS, Birmingham AL, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Dallas TX, Lubbock TX, Jefferson LA, St Louis MO,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Observational Study Protocol: LIVER-R

for
Hepatobiliary Cancers
Location: Dallas TX, Temple TX, Baton Rouge LA, Osage Beach MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06252753

Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Dallas TX, Houston TX, Fairway KS, Kenner LA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Dallas TX, McKinney TX, Houston TX, Kingwood TX,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Dallas TX, Allen TX, McKinney TX, Tyler TX, Temple TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Dallas TX, Arlington TX, Austin TX, Humble TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Dallas TX, Nashville TN, Atlanta GA, Rochester MN,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase 1, Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Houston TX, Saint Louis MO, Birmingham AL,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase 1, Recruiting

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

for
Familial Adenomatous Polyposis
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Recursion Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05552755

Phase 1, Phase 2, Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase 1, Phase 2, Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Dallas TX, Houston TX, Memphis TN, St Louis MO,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 0 - 25

Code: NCT04094610

Phase 1, Phase 2, Recruiting